University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 13 of 29
Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia
NCT03774810
Opioid Taper Study
NCT03912298
Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease
NCT03911141
Task Augmentation of Transcranial Magnetic Stimulation (TMS)
NCT04586205
Remote Observed Dosing of Suboxone to Improve Clinical Practice
NCT03769025
Network Control TMS fMRI
NCT05736458
Behavioral Science and Hepatitis C Screening Outreach
NCT03712553
The Music, Sleep and Dementia Study
NCT04157244
DC Vaccine in Colorectal Cancer
NCT03730948
CART-EGFRvIII + Pembrolizumab in GBM
NCT03726515
Diabetes Reversal and the Subgingival Microbiota
NCT05501093
Study of Therapeutic Exercise in Acute Respiratory Failure to Improve Neuromuscular Disability Trial
NCT03863470
A Randomized Controlled Trial of Imago Relationship Therapy
NCT04302844
Light Treatment Effectiveness (LITE) Study
NCT03726489
Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study
NCT03738332
Disseminating a Digital ACP Platform (Our Care Wishes) to Hospitalized Patients
NCT03727685
Evaluating Risk Factors and Biomarkers for Adaptation and Resilience to Spaceflight
NCT03786016
Enhanced Recovery After Spine Surgery Randomized Clinical Trial
NCT05830331
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
NCT03831503
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103
Imiquimod for Preventing Keloid Recurrence
NCT03760250
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
NCT03482479
BE Intervention for Naloxone Uptake
NCT06064981
Vending Labeling Sales and Intercepts Study
NCT06260176
FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas
NCT03730077
Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL
NCT03792633
Preventing Rehospitalization in Lung Transplant Recipients Utilizing mHealth
NCT03792698
Evaluation of the Novel Use of Gamification With Alternative Goal-setting Experiences
NCT03749473
Chronic Insomnia and CSF Markers of Dementia
NCT04024020
Effects of Insomnia Treatment on Metabolism in Patients With Depression
NCT04719143
Transplanting Hepatitis C Lungs Into Negative Lung Recipients
NCT03724149
Mobile Health (mHealth) Nutrition Intervention for Children With Autism Spectrum Disorder
NCT03424811
Validation of Point of Care Liver Function Tests
NCT03800069
TrueTear in Sjogren's Disease Patients
NCT03719885
PET Imaging in Patients With Suspected Cardiac Sarcoidosis
NCT03746847
Psoriatic Arthritis and Psoriasis Treatment Decision Aid
NCT03737045
Electrogram-Guided Myocardial Advanced Phenotyping
NCT03293381
Automated Navigation to Improve Outpatient Colonoscopy Adherence
NCT03710213
DC Vaccine in Pancreatic Cancer
NCT03592888
Advanced Heart Care at Home
NCT03724695
A Women-Focused PrEP Intervention
NCT03699722
Prospective Use of Awake Endoscopy for Inspire Activation
NCT03990298
The Use of PARO to Decrease Agitation in Persons With Dementia and/or Delirium
NCT05565703
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03585764
Behavioral Weight Loss and Stigma Reduction
NCT03704064
Comparison of a Web-based Advance Directive to a Standard Advance Directive
NCT03676426
Esophageal Cooling for AF Ablation
NCT03691571
Adductor Canal Block (ACB) vs Femoral Nerve Block (FNB) in Revision Total Knee Arthroplasty
NCT03697538
Active Choice in the EHR to Promote Statin Therapy
NCT03271931
Circulating miRNA in Primary Hyperparathyroidism
NCT03931109
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.